Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.875
Bid: 2.80
Ask: 2.95
Change: -0.075 (-2.54%)
Spread: 0.15 (5.357%)
Open: 2.95
High: 2.95
Low: 2.875
Prev. Close: 2.95
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Immedia Picks COO Penney As Interim CEO

Fri, 01st May 2020 14:57

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Friday and not separately reported by Alliance News:

----------

Immedia Group PLC - multi-media content - Chief Operating Officer Ross Penney named interim chief executive, with immediate effect. Bruno Brookes steps down as CEO "to focus on his other interests". Penney joined Immedia in 2006 as part of its acquisition of Cube Music.

----------

Orosur Mining Inc - South American-focused gold developer - hires Brad George as non-executive director. George is a Perth, Australia-based geoscientist with experience in South America and West Africa.

----------

ValiRx PLC - clinical stage biotechnology - Plans to appoint Suzanne Dilly as a director. Dilly has been chief executive officer of subsidiary ValiSeek Ltd since 2014.

----------

Horizon Discovery Group PLC - gene editing and modulation - Hires Siddhartha Kadia as non-executive director, replacing Susan Galbraith, effective Thursday. Kadia was CEO of EAG Laboratories until its acquisition by Eurofins Scientific in 2017. Galbraith currently is head of Early Oncology at AstraZeneca PLC, leaving Horizon Discovery due to increased responsibilities there, Horizon said.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
9 Feb 2016 14:17

ValiRx confident in two ongoing clinical trials

(ShareCast News) - ValiRx was confident in the potential of two of its compounds on Tuesday, in its quarterly update on its ongoing clinical trials. The AIM-traded life science firm, with a focus on cancer diagnostics and therapeutics for personalised medicine, said that recent testing had shown VAL

Read more
9 Feb 2016 10:42

WINNERS & LOSERS SUMMARY: Bond Disclosure Sends Legal & General Higher

Read more
9 Feb 2016 09:15

ValiRx Shares Rise After Positive Clinical Trial News For VAL201

Read more
19 Nov 2015 11:40

ValiRx Says VAL201 Dose Escalation Complete, Preparing VAL401 Trials

Read more
5 Nov 2015 10:39

ValiRx Opens US Office In Boston, Massachusetts

Read more
27 Oct 2015 08:41

ValiRx Inks Three-Year Collaboration Deal With Finland's Pharmatest

Read more
1 Oct 2015 06:50

ValiRx Granted New Biomarker Patent In Japan

Read more
17 Sep 2015 11:40

ValiRx Loss Widens Slightly As It Continues Compound Development

Read more
16 Sep 2015 07:27

ValiRx Raises GBP2.5 Million In Subscription, Agrees Equity Swap (ALLISS)

Read more
6 Aug 2015 08:15

ValiRx Strikes Collaboration Deal With University Of Leeds Professor

Read more
21 Jul 2015 11:08

LONDON MARKET MIDDAY: US Stocks Seen Mixed As Tech Giants Report

Read more
21 Jul 2015 08:52

WINNERS & LOSERS SUMMARY: AO World Surges But IG Group Falls

Read more
21 Jul 2015 07:10

ValiRx Provides Positive Update For Ongoing VAL201 Trial

Read more
16 Jul 2015 09:11

ValiRx's ValiSeek Joint Venture Starts Clinical Trial For VAL401

Read more
25 Jun 2015 08:12

ValiRx Says VAL201 Compound Trial To Advance To Dose Escalation

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.